Effect of Zinc in treatment of Psoriasis

Phase 3

• Conditions: Plaque Type Psoriasis with Skin Involvement Under 20%.; Small plaque parapsoriasis; L41.3

• Registration Number: IRCT20191022045186N1
• Lead Sponsor: Ardabil University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Plaque Type Psoriasis Patients with Skin Involvement Under 20% with Serum Zinc Defficiency

Exclusion Criteria

Patients with Gastrointestinal Problems and Malabsorption Syndrome

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Difference in itching of plaques. Timepoint: Before intervention, 14, 30, 60, 90, 120 days after intervention. Method of measurement: Severity mentioned by patient according to BSA and PASI indexes.;Difference in erythem of plaques. Timepoint: Before intervention, 14, 30, 60, 90, 120 days after intervention. Method of measurement: Severity mentioned by patient according to BSA and PASI indexes.;Difference in scaling of plaques. Timepoint: Before intervention, 14, 30, 60, 90, 120 days after intervention. Method of measurement: Severity mentioned by patient according to BSA and PASI indexes.;Difference in surface area of plaques. Timepoint: Before intervention, 14, 30, 60, 90, 120 days after intervention. Method of measurement: Severity mentioned by patient according to BSA and PASI indexes.;Difference in induration of plaques. Timepoint: Before intervention, 14, 30, 60, 90, 120 days after intervention. Method of measurement: Severity mentioned by patient according to BSA and PASI indexes.